Zobrazeno 1 - 1
of 1
pro vyhledávání: '"M. J. Papagno"'
Autor:
M. Cosatti, M. E. D´ Angelo, I. E. Petkovic, N. Kogan, D. A. Pereira, Y. Tissera, M. V. Toledo, C. G. Alonso, L. Garcia, M. Severina, M. Rosemffet, A. Bertoli, M. Delavega, V. Cosentino, H. Maldonado Ficco, C. Calle Montoro, S. S. De la Vega Fernandez, G. Berbotto, A. Rollano Perasso, A. B. Gómez Vara, M. Landi, E. Velozo, M. E. Sattler, L. Perrotat, R. A. Ezquer, J. Flores Trejo, P. Farfan, R. Rojas Tessel, V. Carrizo Abarza, J. M. Bande, B. Hernandez, M. J. Papagno, L. A. Rodriguez, V. Martin Koller, F. Montoya, J. Kreimer, P. C. Luna, C. Echeverria, B. M. Virasoro, K. Roberts, C. A. Isnardi, E. E. Schneeberger, G. Pons-Estel, C. Pisoni
Publikováno v:
Annals of the Rheumatic Diseases. 81:929.1-929
BackgroundPatients with rheumatic diseases (RD) have been excluded from SARS-CoV-2 vaccine trials, though data appear to show safety and efficacy, mostly evidence remains in mRNA vaccines. In our country, adenovirus-vector, inactivated and heterologo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7e0ebe81d2ede2bb5acb911880c09f7e
https://doi.org/10.1136/annrheumdis-2022-eular.796
https://doi.org/10.1136/annrheumdis-2022-eular.796
